Outsourced Pharma Capabilities Update: Small Molecule Drug Product Innovation

Who should attend: Individuals working for pharma companies with active small molecule development pipelines, CMC and formulation development experts, manufacturing teams, and supply chain and procurement professionals. Industry consultants, capital investment firms, and CDMO sponsors are all welcome to attend as well. 

Complete this form to
download the whitepaper

Outsourced Pharma Capabilities Update: Small Molecule Drug Product Innovation

@Outsourced Pharma

Subscribe To Our Newsletter

Join our email list to get the exclusive unpublished content right in your inbox